Delivery Order SPE2DB22D3301-SPE2DB24FZ2AF
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$88K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,542.95 firm fixed-price delivery order contract is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The contract has an ultimate completion date of February 2, 2024 and was awarded on February 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,335.54 firm fixed-price contract provides for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a prescription medication, with a completion date of February 14, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $86,220.14 under the Defense Logistics Agency's (DLA) Indefinite Delivery Contract (IDC) for medical supplies and pharmaceuticals. The contract covers the delivery of 4559601204 - RINVOQ ER 15 MG TABLET UU 30S, a medication used to treat certain autoimmune disorders. This IDC, worth up to $999,999,999 and running through November 2026, serves as a key contracting vehicle for the DLA to procure a wide range...
This federal contract award, valued at $3,734.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract is a Delivery Order (SPE2DX15D3020|SPE2DX25FPYQB) with a Firm Fixed Price structure, valued at $36,622.16, and has an ultimate completion date of December 10, 2024. The contract provides for the delivery of RINVOQ ER 30 MG TABLET medical supplies. This award is part of a...
This federal contract award is a Delivery Order for $96,329.87 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of a prescription medication, RINVOQ ER 45 MG TABLET, with a performance period ending on September 19, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award is a delivery order with a ceiling value of $37,324.29 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication, to the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price arrangement with an ultimate completion date of June 6, 2024. It is not designated as a set-aside contract. In addition...
The U.S. Defense Logistics Agency (DLA) awarded a $4,707.34 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 10, 2025. The contract, which runs through February 11, 2025, is for the provision of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $17,614.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,022.66 firm fixed-price delivery order contract is for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, with a completion date of January 7, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...